The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism
Open accessAbstract
The most common transposable genetic element in humans, long interspersed element 1 (L1), constitutes about 20% of the genome. The activity of L1 and related transposons such as Alu elements causes disease and contributes to speciation. Little is known about the cellular mechanisms that control their spread. We show that expression of human APOBEC3B or APOBEC3F decreased the rate of L1 retrotransposition by 5-10-fold. Expression of two related proteins, APOBEC3D or APOBEC3G, had little effect. The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic. Two lines of evidence indicated that these APOBEC3 proteins use a deamination-independent mechanism to inhibit L1. First, a catalytically inactive APOBEC3B mutant maintained L1 inhibition activity. Second, cDNA strand-specific C --> T hypermutations were not detected among L1 elements that had replicated in the presence of APOBEC3B or APOBEC3F. In addition, lower levels of retrotransposed L1 DNA accumulated in the presence of APOBEC3B and APOBEC3F. Together, these data combined to suggest a model in which APOBEC3B or APOBEC3F provide a preintegration barrier to L1 retrotransposition. A particularly high level of APOBEC3F protein in human testes and an inverse correlation between L1 activity and APOBEC3 gene number suggest the relevance of this mechanism to mammals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics
Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A.-K., Amini, B., Andersen, E., Andersson, A.-C., Angelidou, P., Asplund, A., Asplund, C., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500279-mcp200 · Cited by 1,540
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Self-citationHot L1s account for the bulk of retrotransposition in the human population
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., & Kazazian, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831042100 · Cited by 1,073
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
High frequency retrotransposition in cultured mammalian cells
Moran, J. V., Holmes, S. E., Naas, T. P., DeBerardinis, R. J., Boeke, J. D., & Kazazian, H. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81998-4 · Cited by 1,022
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
Biology of Mammalian L1 Retrotransposons
Ostertag, E. M., & Kazazian Jr, H. H. (2001) · Annual Review of Genetics · doi:10.1146/annurev.genet.35.102401.091032 · Cited by 765
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins
Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S.-J., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 619
RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators
Harris, R. S., Petersen-Mahrt, S. K., & Neuberger, M. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00742-6 · Cited by 603
Self-citationAncient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
Sawyer, S. L., Emerman, M., & Malik, H. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020275 · Cited by 485
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
Mobile elements and mammalian genome evolution
Deininger, P. L., Moran, J. V., Batzer, M. A., & Kazazian, H. H. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.10.013 · Cited by 479
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Self-citationKhan, H., Smit, A., & Boissinot, S. (2006) · Genome Research · doi:10.1101/gr.4001406 · Cited by 372
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
Esnault, C., Heidmann, O., Delebecque, F., Dewannieux, M., Ribet, D., Hance, A. J., Heidmann, T., & Schwartz, O. (2005) · Nature · doi:10.1038/nature03238 · Cited by 346
Complementary function of the two catalytic domains of APOBEC3G
Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., & Landau, N. R. (2005) · Virology · doi:10.1016/j.virol.2005.01.011 · Cited by 305
Suspène, R., Guétard, D., Henry, M., Sommer, P., Wain-Hobson, S., & Vartanian, J.-P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408223102 · Cited by 304
APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication
Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D., & Landau, N. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408802200 · Cited by 293
Determination of L1 retrotransposition kinetics in cultured cells
Ostertag, E. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.6.1418 · Cited by 291
Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors
Cullen, B. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1067-1076.2006 · Cited by 284
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
Bogerd, H. P. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj416 · Cited by 273
Branciforte, D., & Martin, S. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2584 · Cited by 238
Haché, G., Liddament, M. T., & Harris, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500382200 · Cited by 189
Self-citationShindo, K., Takaori-Kondo, A., Kobayashi, M., Abudu, A., Fukunaga, K., & Uchiyama, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300376200 · Cited by 180
Russell, R. A., Wiegand, H. L., Moore, M. D., Schäfer, A., McClure, M. O., & Cullen, B. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8724-8731.2005 · Cited by 177
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast
Schumacher, A. J., Nissley, D. V., & Harris, R. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501694102 · Cited by 147
Self-citationRestriction of Foamy Viruses by APOBEC Cytidine Deaminases
Delebecque, F., Suspène, R., Calattini, S., Casartelli, N., Saı̈b, A., Froment, A., Wain–Hobson, S., Gessain, A., Vartanian, J., & Schwartz, O. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.605-614.2006 · Cited by 147
APOBEC3G targets human T-cell leukemia virus type 1
Sasada, A., Takaori‐Kondo, A., Shirakawa, K., Kobayashi, M., Aierkin, A., Hishizawa, M., Imada, K., Tanaka, Y., & Uchiyama, T. (2005) · Retrovirology · doi:10.1186/1742-4690-2-32 · Cited by 143
APOBEC‐mediated interference with hepadnavirus production†
Rösler, C., Köck, J., Kann, M., Malim, M. H., Blum, H. E., Baumert, T. F., & von Weizsäcker, F. (2005) · Hepatology · doi:10.1002/hep.20801 · Cited by 135
Inhibition of a Yeast LTR Retrotransposon by Human APOBEC3 Cytidine Deaminases
Dutko, J. A., Schäfer, A., Kenny, A. E., Cullen, B. R., & Curcio, M. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.051 · Cited by 134
Turelli, P., Vianin, S., & Trono, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400334200 · Cited by 71
Unedited inhibition of HBV replication by APOBEC3G
Seppen, J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.008 · Cited by 20
Cited by
Harris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 551
Self-citationRestricting retrotransposons: a review
Goodier, J. L. (2016) · Mobile DNA · doi:10.1186/s13100-016-0070-z · Cited by 436
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
The APOBEC Protein Family: United by Structure, Divergent in Function
Salter, J. D., Bennett, R. P., & Smith, H. C. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.05.001 · Cited by 408
Refsland, E. W., Stenglein, M. D., Shindo, K., Albin, J. S., Brown, W. L., & Harris, R. S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq174 · Cited by 363
Self-citation
Metadata
- Authors
- Stenglein, M. D., & Harris, R. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 281
- Issue
- 25
- Pages
- 16837-16841
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1966477735
- Cited by
- 277
- References
- 36
- FWCI
- 35.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.